UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Once-weekly prophylactic treatment vs. on-demand treatment with nonacog alfa in patients with moderately severe to severe haemophilia B

Haemophilia : the official journal of the World Federation of Hemophilia, 2016-05, Vol.22 (3), p.381-388

2016

Volltextzugriff (PDF)

Dual role of the CXCL12 polymorphism in patients with chronic lymphocytic leukemia

HLA, 2016-06, Vol.87 (6), p.432-438

2016

Volltextzugriff (PDF)

Variations in genes involved in regulation of the nuclear factor - κB pathway and the risk of acute myeloid leukaemia

International journal of immunogenetics, 2016-04, Vol.43 (2), p.101-106

2016

Volltextzugriff (PDF)

Immune Thrombocytopenia and JAK2V617F Positive Essential Thrombocythemia: Literature Review and Case Report

Case reports in hematology, 2017-01, Vol.2017 (2017), p.1-4

2017

Volltextzugriff (PDF)

Addition of cladribine to daunorubicin and cytarabine increases complete remission rate after a single course of induction treatment in acute myeloid leukemia. Multicenter, phase III study

Leukemia, 2004-05, Vol.18 (5), p.989-997

2004

Volltextzugriff (PDF)

Association studies of CTLA-4, CD28 , and ICOS gene polymorphisms with B-cell chronic lymphocytic leukemia in the Polish population

Human immunology, 2008-03, Vol.69 (3), p.193-201

2008

Volltextzugriff (PDF)

Clinical assessment of Optivate®, a high-purity concentrate of factor VIII with von Willebrand factor, in the management of patients with haemophilia A

Haemophilia : the official journal of the World Federation of Hemophilia, 2011-05, Vol.17 (3), p.456-462

2011

Volltextzugriff (PDF)

Alterations of the expression of T-cell-related costimulatory CD28 and downregulatory CD152 (CTLA-4) molecules in patients with B-cell chronic lymphocytic leukaemia

British journal of cancer, 2004-05, Vol.90 (10), p.2042-2048

2004

Volltextzugriff (PDF)

Pharmacokinetics of Optivate®, a high-purity concentrate of factor VIII with von Willebrand factor, in patients with severe haemophilia A

Haemophilia : the official journal of the World Federation of Hemophilia, 2011-03, Vol.17 (2), p.185-190

2011

Volltextzugriff (PDF)

TGF-β1 gene polymorphisms influence the course of the disease in non-Hodgkin's lymphoma patients

Cytokine (Philadelphia, Pa.), 2006-02, Vol.33 (3), p.145-149

2006

Volltextzugriff (PDF)

Bortezomib plus Melphalan and Prednisone for Initial Treatment of Multiple Myeloma

The New England journal of medicine, 2008-08, Vol.359 (9), p.906-917

2008

Volltextzugriff (PDF)

Safety and efficacy of eltrombopag for treatment of chronic immune thrombocytopenia: results of the long-term, open-label EXTEND study

Blood, 2013-01, Vol.121 (3), p.537-545

2013

Volltextzugriff (PDF)

Increased monocyte chemoattractant protein 1 (MCP-1/CCL-2) serum level in acute myeloid leukemia

Neoplasma, 2007, Vol.54 (4), p.285

2007

Volltextzugriff (PDF)

Eltrombopag before Procedures in Patients with Cirrhosis and Thrombocytopenia

The New England journal of medicine, 2012-08, Vol.367 (8), p.716-724

2012

Volltextzugriff (PDF)

Cladribine with or without prednisone in the treatment of previously treated and untreated B‐cell chronic lymphocytic leukaemia — updated results of the multicentre study of 378 patients

British journal of haematology, 2000-02, Vol.108 (2), p.357-368

2000

Volltextzugriff (PDF)

LYVE-1 expression on high endothelial venules (HEVs) of lymph nodes

Lymphology, 2005-09, Vol.38 (3), p.107-110

2005

Volltextzugriff (PDF)

Interleukin‐17 in acute myeloid leukemia

Journal of cellular and molecular medicine, 2003-10, Vol.7 (4), p.472-474

2003

Volltextzugriff (PDF)

Expression of bone morphogenetic proteins (BMPs) receptors in patients with B-cell chronic lymphocytic leukemia (B-CLL)

International journal of laboratory hematology, 2010-12, Vol.32 (6p1), p.e217-e221

2010

Volltextzugriff (PDF)

A multicenter, open, noncomparative, phase II study of the combination of cladribine (2-chlorodeoxyadenosine), cytarabine, granulocyte colony-stimulating factor and mitoxantrone as induction therapy in refractory acute myeloid leukemia: a report of the Polish Adult Leukemia Group

Annals of hematology, 2005-09, Vol.84 (9), p.557-564

2005

Volltextzugriff (PDF)

A multicenter, open, non-comparative, phase II study of the combination of cladribine (2-chlorodeoxyadenosine), cytarabine, and G-CSF as induction therapy in refractory acute myeloid leukemia - a report of the Polish Adult Leukemia Group (PALG)

European journal of haematology, 2003-09, Vol.71 (3), p.155-162

2003

Volltextzugriff (PDF)

Lack of association between the TNF-α promoter gene polymorphism and susceptibility to B-cell chronic lymphocytic leukaemia

International Journal of Immunogenetics, 2006-02, Vol.33 (1), p.21-24

2006

Volltextzugriff (PDF)

Endostatin serum level in acute myeloid leukemia

Neoplasma, 2005, Vol.52 (2), p.182

2005

Volltextzugriff (PDF)

sVE-cadherin and sCD146 serum levels in patients with multiple myeloma

Clinical and laboratory haematology, 2006-02, Vol.28 (1), p.36-39

2006

Volltextzugriff (PDF)

Epithelial bone marrow cells in patients with advanced esophageal squamous cell carcinoma

Neoplasma, 2009, Vol.56 (3), p.245-251

2009

Volltextzugriff (PDF)

1 – 25 von 158

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(134)
Mit Volltextzugriff
(89)

Publikationsform

Sprache

Englisch
(113)
Polnisch
(45)

Erscheinungsjahr

n.n

Thema

Humans
(118)
Middle Aged
(81)
Adult
(75)
Male
(75)
Female
(74)
Science & Technology
(73)
Life Sciences & Biomedicine
(72)
Aged
(59)
Aged, 80 And Over
(29)
Hematology
(28)
Oncology
(27)
Biological And Medical Sciences
(23)
Medical Sciences
(23)
Adolescent
(19)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(19)
Prognosis
(16)
Immunology
(15)
Case-Control Studies
(12)
Hematologic And Hematopoietic Diseases
(12)
Treatment Outcome
(12)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Once-weekly prophylactic treatment vs. on-demand treatment with nonacog alfa in patients with moderately severe to severe haemophilia B

Dual role of the CXCL12 polymorphism in patients with chronic lymphocytic leukemia

Variations in genes involved in regulation of the nuclear factor - κB pathway and the risk of acute myeloid leukaemia

Immune Thrombocytopenia and JAK2V617F Positive Essential Thrombocythemia: Literature Review and Case Report

Addition of cladribine to daunorubicin and cytarabine increases complete remission rate after a single course of induction treatment in acute myeloid leukemia. Multicenter, phase III study

Association studies of CTLA-4, CD28 , and ICOS gene polymorphisms with B-cell chronic lymphocytic leukemia in the Polish population

Clinical assessment of Optivate®, a high-purity concentrate of factor VIII with von Willebrand factor, in the management of patients with haemophilia A

Alterations of the expression of T-cell-related costimulatory CD28 and downregulatory CD152 (CTLA-4) molecules in patients with B-cell chronic lymphocytic leukaemia

Pharmacokinetics of Optivate®, a high-purity concentrate of factor VIII with von Willebrand factor, in patients with severe haemophilia A

TGF-β1 gene polymorphisms influence the course of the disease in non-Hodgkin's lymphoma patients

Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study

Bortezomib plus Melphalan and Prednisone for Initial Treatment of Multiple Myeloma

Safety and efficacy of eltrombopag for treatment of chronic immune thrombocytopenia: results of the long-term, open-label EXTEND study

Increased monocyte chemoattractant protein 1 (MCP-1/CCL-2) serum level in acute myeloid leukemia

Eltrombopag before Procedures in Patients with Cirrhosis and Thrombocytopenia

Cladribine with or without prednisone in the treatment of previously treated and untreated B‐cell chronic lymphocytic leukaemia — updated results of the multicentre study of 378 patients

LYVE-1 expression on high endothelial venules (HEVs) of lymph nodes

Interleukin‐17 in acute myeloid leukemia

Expression of bone morphogenetic proteins (BMPs) receptors in patients with B-cell chronic lymphocytic leukemia (B-CLL)

A multicenter, open, noncomparative, phase II study of the combination of cladribine (2-chlorodeoxyadenosine), cytarabine, granulocyte colony-stimulating factor and mitoxantrone as induction therapy in refractory acute myeloid leukemia: a report of the Polish Adult Leukemia Group

A multicenter, open, non-comparative, phase II study of the combination of cladribine (2-chlorodeoxyadenosine), cytarabine, and G-CSF as induction therapy in refractory acute myeloid leukemia - a report of the Polish Adult Leukemia Group (PALG)

Lack of association between the TNF-α promoter gene polymorphism and susceptibility to B-cell chronic lymphocytic leukaemia

Endostatin serum level in acute myeloid leukemia

sVE-cadherin and sCD146 serum levels in patients with multiple myeloma

Epithelial bone marrow cells in patients with advanced esophageal squamous cell carcinoma

Suchergebnisse filtern